Among them were known cancer/testis antigen genes (PNMA5, SPATA22, ROR1, and CT45A6) and some new candidates (PAX2, HES4, PEG10, NTN4, PDE10A, and POSTN), these genes could be useful tumor markers and potential therapeutic targets. This evidence concerns the gene PAX2 and neoplasm.